Top 10 fortressbiotech.com Competitors

sentynl.com

CHMP recommendation for approval of NULIBRY in the European Union (EU) for the treatment of patients with molybdenum cofactor deficiency (MoCD) Type A is based on the efficacy and safety data collected to date compared to data from a natural history study  Under an accelerated assessment pathway, a decision by the European Commission (EC), which [...]

nurixtx.com

Browse current openings at Nurix across research, clinical, and business roles. Find your next opportunity. We'd love to hear from you.

sunpharma.com

sun pharma is the fourth largest global specialty generic pharmaceutical company with a presence in more than 100 countries.

globusmedical.com

We deliver the highest quality products to patients with complex spinal pathologies. Learn more about Globus' featured spine technologies and procedures.

cell-medicine.com

35. 現在まで自家がんワクチン療法の試みは3790例以上とのことですが、再発抑制、病巣縮小、QOL改善などの状況について教えてください。 自家がんワクチンやがん免疫療法のみなさまから寄せられる質問とその回答をご紹介します。

moonlaketx.com

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company that provides next-level therapies to elevate care.

drugstorenews.com

DSN is the No. 1 source of news, knowledge and networking for professionals in the multibillion dollar retail pharmacy marketplace.

pharmexec.com

Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.